Transplant Diagnostics Market Worth 4.91 Billion USD by 2023

Transplant Diagnostics Market Worth 4.91 Billion USD by 2023

This market is projected to reach USD 4.91 billion by 2023 from USD 3.44 billion in 2018, at a CAGR of 7.4%.

Share it

According to a new market research report “Transplant Diagnostics Market by Technology (PCR, NGS, Sanger Sequencing), Product (Instrument, Reagent, Software), Application (HLA, Blood Profile, Pathogen Detection), Type (Heart, Kidney, Liver, Stem Cell), End User (Hospital) -Global Forecast to 2023”, published by MarketsandMarkets™, the market is projected to reach USD 4.91 billion by 2023 from USD 3.44 billion in 2018, at a CAGR of 7.4%.

Factors such as the increasing patient emphasis on effective and early patient profiling during organ transplantation and growing adoption of transplant diagnostic techniques in related research studies are driving the growth of the Transplant Diagnostics Market.

Based on product, the reagents and consumables segment is estimated to have the largest share of the market in 2018.

On the basis of product, the Transplant Diagnostics Market is segmented into reagents & consumables, instruments, and software & services. The reagents & consumables segment is expected to account for the largest share of the global Transplant Diagnostics Market in 2018. Factors such as the increasing patient emphasis on effective and early patient profiling during organ transplantation, and growing adoption of transplant diagnostic techniques in related research studies are driving the growth of this segment.

Based on technology, the molecular assays segment is expected to witness the highest growth during the forecast period.

On the basis of technology, the Transplant Diagnostics Market is segmented into molecular assay and non-molecular assay technology. The molecular assay technology segment is expected to register the highest CAGR during the forecast period. Factors such as its varied applications in patient profiling, rising public-private investments to support product development, and increasing clinical evidence to establish clinical efficacy of molecular assay techniques are driving the growth of this segment.

Based on transplant type, the solid organ transplantation segment is expected to account for the largest share of this market in 2018.

On the basis of transplant type, the Transplant Diagnostics Market is categorized into solid organ, stem cell, and soft tissue transplantation. Solid organ transplantation is expected to account for the largest share of the Transplant Diagnostics Market in 2018. The supportive government regulations to increase organ donations across major healthcare markets, rising number of chronic diseases/disorders that leads to transplantation, and ongoing technological advancements in the field of transplant diagnostics are the key factors supporting the growth of the Transplant Diagnostics Market for solid organ transplantation.

Share it

Leave a Reply

Your email address will not be published. Required fields are marked *